Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 19 | $939,367 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Sep 2024 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 09 Sep 2024 | Sale | 3,195 | 14.971 | 47,832 | D |
10 Jul 2024 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 08 Jul 2024 | Sale | 1,758 | 14.95 | 26,282 | D |
08 Mar 2024 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Mar 2024 | Sale | 4,086 | 12.3067 | 50,285 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 26 Dec 2023 | Sale | 94 | 16.67 | 1,567 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 3,677 | 16.4837 | 60,611 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 6,529 | 15.2417 | 99,513 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Dec 2023 | Sale | 2,200 | 15.0703 | 33,155 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 46 | 14.03 | 645 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 904 | 13.4522 | 12,161 | D |
12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 11 Jul 2023 | Sale | 3,884 | 17.9979 | 69,904 | D |
12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 10 Jul 2023 | Sale | 6,116 | 17.9788 | 109,958 | D |
23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,907 | 15.1711 | 135,129 | D |
23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,593 | 14.8399 | 127,519 | D |
03 Mar 2023 16:37 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Mar 2023 | Sale | 145 | 11.2282 | 1,628 | D |
03 Mar 2023 16:37 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Mar 2023 | Sale | 1,602 | 10.4625 | 16,761 | D |
12 Dec 2022 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 08 Dec 2022 | Sale | 4,550 | 18.9534 | 86,238 | D |
06 Dec 2022 17:02 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 05 Dec 2022 | Sale | 200 | 18.05 | 3,610 | D |
06 Dec 2022 17:02 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Dec 2022 | Sale | 2,910 | 18.1957 | 52,949 | D |
18 Nov 2022 16:59 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Nov 2022 | Sale | 200 | 18.1 | 3,620 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)